CLINICAL AND IMMUNOLOGICAL ASPECTS OF T C ELL-BASED VACCINE THERAPY IN PATIENTS WITH PROGREDIENT MULTIPLE SCLEROSIS
https://doi.org/10.15789/1563-0625-2012-1-2-103-108
Abstract
About the Authors
G. SeledtsovaRussian Federation
I. Ivanova
Russian Federation
S. Mamaev
Russian Federation
D. Seledtsov
Russian Federation
N. Malkova
Russian Federation
V. Seledtsov
Russian Federation
V. I. Seledtsov
References
1. Иванова И.П.. Селедцов В.И., Банул Н.В., Самарин Д.М., Селедцова Г.В., Савкин И.В., Ширинский В.С., Пронкина Н.В., Козлов В.А. Получение Т-клеточной вакцины и ее применение для лечения рассеянного склероза // Мед. Иммунология. – 2005. – Т. 7, № 1. – С. 27-32.
2. Иванова И.П., Селедцов В.И., Селедцова Г.В., Мамаев С.В., Потемкин А.В., Селедцов Д.В., Козлов В.А. Индукция антиидиотипического иммунного ответа аутологичной Т-клеточной вакциной у больных рассеянным склерозом // Клеточные технологии в биологии и медицине. – 2008. – № 3. – С. 145-149.
3. Stinissen P., Zhang J., Vandevyver C., Hermans G., Raus J. Gammadelta T cell responses to activated T cells in multiple sclerosis patients induced by T cell vaccination // J. Neuroimmunol. – 1998. – N 87. – P. 94-104.
4. Giuliani F., Yong V. Immune-mediated neurodegeneration and neuroprotection in MS // Int. MS J. – 2003. – N 10. – P. 122-130.
5. Giuliani F., Goodyer C., Antel J., Yong V. Vulnerability of human neurons to T cell-mediated cytotoxicity // J. Immunol. – 2003. – N. 171. – P. 368-379.
6. Okun E., Mattson M., Arumugam T. Involvement of Fc receptors in disorders of the central nervous system // Neuromolecular Med. – 2010. – N 12 (2). – Р. 164-178.
7. Correale J., Lund B., McMillan M., Ko D., McCarthy K., Weiner L. T cell vaccination in secondary progressive multiple sclerosis // J. Neuroimmunol. – 2000. – N 107. – P. 130-139.
8. Correale J., Farez M., Gilmore W. Vaccines for Multiple Sclerosis : Progress to Date // CNS Drugs. – 2008. – N 22. – P. 175-198.
9. Orduno N., Quach T., Sanz1 I. B cells and immunological tolerance // J. Invest. Dermatol. – 2009. – Vol. 129 (2). – P. 278-288.
10. Gutcher I., Urich E., Wolter K., Prinz M., Becher B. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation // Nat. Immunol. – 2006. – N 7. – P. 946-953.
11. Nicoletti F., Di Marco R., Mangano K., Patti F., Reggio E., Nicoletti A., Bendtzen K., Reggio A. Increased serum levels of interleukin-18 in patients with multiple sclerosis // Neurology. – 2001. – N 57 (2). – P. 342-344.
12. Huang W.X., Huang P., Hillert J. Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis // Multiple Sclerosis Jornal. – 2004. – N 10. – P. 482-487.
13. Gutcher I., Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation // J. Clin. Invest. – 2007. – Vol. 117. – P. 1119-1127.
Review
For citations:
Seledtsova G., Ivanova I., Mamaev S., Seledtsov D., Malkova N., Seledtsov V., Seledtsov V.I. CLINICAL AND IMMUNOLOGICAL ASPECTS OF T C ELL-BASED VACCINE THERAPY IN PATIENTS WITH PROGREDIENT MULTIPLE SCLEROSIS. Medical Immunology (Russia). 2012;14(1-2):103-108. (In Russ.) https://doi.org/10.15789/1563-0625-2012-1-2-103-108